Expression of vascular endothelial growth factor in renal cell carcinoma and the relation to angiogenesis and p53 protein expression

Journal of Surgical Oncology

Volumn 77, Issue 1, 2001, Pages 55-60

  Lee, Ji Shin ^a   Kim, Hyung Seok ^a   Jung, Jong Jae ^a   Park, Chang Soo ^b   Lee, Min Cheol ^b  

^a Seonam University   (South Korea)

^b Chonnam National University Medical School   (South Korea)

Author keywords

p53, angiogenesis; Renal cell carcinoma; Vascular endothelial growth factor

Indexed keywords

PROTEIN ANTIBODY; PROTEIN P53; VASCULOTROPIN; VASCULOTROPIN ANTIBODY;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DENSITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

ADULT; AGED; CARCINOMA, RENAL CELL; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; KIDNEY NEOPLASMS; LYMPHOKINES; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; TUMOR SUPPRESSOR PROTEIN P53; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0035042373     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/jso.1066     Document Type: Article

References (29)

1. What is the evidence that tumors are angiogenesis dependent?
2. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
3. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
4. Prognostic value of vascular endothelial growth factor expression in gastric carcinoma
5. Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma: Association with angiogenesis and tumor progression
6. Vascular endothelial growth factor and platelet-derived growth factor are potential angiogenic and metastatic factors in human breast cancer
7. Significance of vascular endothelial growth factor messenger RNA expression in primary lung cancer
8. Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptor in kidney and bladder carcinomas
9. Markedly increased amounts of messenger RNAs for vascular endothelial growth factor and placenta growth factor in renal cell carcinoma associated with angiogenesis
10. Vascular endothelial growth factor expression is increased in renal cell carcinoma
11. Tubulogenesis by microvascular endothelial cells is mediated by vascular endothelial growth factor (VEGF) in renal cell carcinoma
12. Renal cell carcinoma: Relevance of angiogenetic factors
13. Quantification by competitive quantitative RT-PCR of VEGF121 and VEGF165 in renal cell carcinoma
14. Vascular endothelial growth factor as prognostic factor in renal cell carcinoma
15. Expression pattern of vascular endothelial growth factor isoform is closely correlated with tumor stage and vascularization in renal cell carcinoma
16. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
17. p53 potentiates protein kinase C induction of vascular endothelial growth factor expression
18. Wild-type p53 and v-Src exert opposing influences on human vascular endothelial growth factor gene expression
19. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1
20. Vascular endothelial growth factor and glioma angiogenesis: Coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanism
21. Neoangiogenesis and p53 protein in lung cancer: Their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression
22. In oesophageal squamous cell carcinoma vascular endothelial growth factor is associated with p53 mutation, advanced stage and poor prognosis
23. Vascular endothelial growth factor and nitric oxide synthase expression in human lung cancer and the relation to p53
24. Prognostic significance of morphologic parameters in renal cell carcinoma
25. Complete one-hour immunohistochemistry based on capillary action
26. Association of immunohistochemical staining for p53 with metastatic progression and poor survival in patients with renal cell carcinoma
27. Microvessel quantitation and prognosis in invasive breast carcinoma
28. Tumor vascularity correlates with the prognosis of patients with esophageal squamous cell carcinoma